Last week, the British-Swiss Chamber of Commerce’s Life Science Task Force hosted an event that showed just how much momentum there is in cross-border MedTech collaboration. Held at Zühlke Group in Zürich, it brought together 30 innovators, public funding bodies, private investors, and stakeholders from both the UK and Switzerland.

The first panel looked at how UK and Swiss startups are moving from lab results to patient impact. Moderated by Phil Norris (machineMD), it featured Clémence Hermann (Spirecut), Christian Mirkes (SKOPE MRI), Matt Curran (Nanoflex Robotics), Nicolas Bouduban (Swiss m4m Center), and Martin Hofmann (University of Bern).

The group emphasized the importance of working across borders—not just for research, but also to navigate regulations, scale effectively, and reach markets more efficiently. The takeaway was simple: collaboration makes innovation real, and real innovation gets to patients quicker.

At Spirecut, this collaborative approach is already underway. Backed by a UK-Swiss Innovation Grant awarded in 2023, we’re working with Professor Joanne Lord at the University of Southampton and our UK distributor, Sovereign Medical, on a health economics study. This project shows how bilateral funding can give startups the tools to generate solid evidence, demonstrate value, and ultimately expand patient access.

Learn more about our grant here.